A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the Snap-02 Italian Collaborative Study

Author:

Lissoni A.A.,Colombo N.,Pellegrino A.,Parma G.,Zola P.,Katsaros D.,Chiari S.,Buda A.,Landoni F.,Peiretti M.,Dell’Anna T.,Fruscio R.,Signorelli M.,Grassi R.,Floriani I.,Fossati R.,Torri V.,Rulli E.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference11 articles.

1. Concurrent Chemoradiation for Cervical Cancer. Clinical Announcement;National Cancer Institute,1999

2. Neoadjuvant chemotherapy locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials;Neoadjuvant Chemotherapy for Cervical Cancer Meta-analysis Collaboration;Eur J Cancer,2003

3. Neoadjuvant chemotherapy for locally advanced cervix cancer;Neoadjuvant Chemotherapy for Cervical Cancer Meta-Analysis Collaboration (NACCCMA) Collaboration;Cochrane Database Syst Rev,2004

4. Randomized Trial of Neoadjuvant Chemotherapy Comparing Paclitaxel, Ifosfamide, and Cisplatin With Ifosfamide and Cisplatin Followed by Radical Surgery in Patients With Locally Advanced Squamous Cell Cervical Carcinoma: The SNAP01 (Studio Neo-Adjuvante Portio) Italian Collaborative Study

5. Staging classifications and clinical practice guidelines of gynaecologic cancers;FIGO Committee on Gynecologic Oncology;Int J Gynecol Obstet,2000

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3